3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Children's Health -

New Techniques Offer Valuable Tools in Analysis of Congenital Anomalies

Children's HealthJun 08, 10

New techniques to detect chromosomal abnormalities can offer a higher degree of accuracy. Chromosomal abnormalities are a well-known cause of multiple congenital anomalies, and conventional methods of culture analysis have proven unsuccessful in 10% to 40% of cases. Comparative genomic hybridization (CGH) and fluorescent in situ hybridization (FISH) techniques were tested and found successful by analyzing tissue from children who had multiple congenital anomalies.

The May issue of the journal Pediatric and Developmental Pathology reports results from this study, which examined the feasibility of CGH and FISH in retrospective genetic analysis to detect chromosomal abnormalities.

CGH is a new molecular technique that allows the entire genome to be analyzed in frozen or paraffin-embedded tissue. It is based on DNA rather than metaphase cultures like traditional methods of analysis.

The FISH technique can be used to confirm the CGH findings or detect abnormalities that CGH could not. FISH analysis is specifically directed at certain chromosomal regions.

This study used DNA from the postmortem tissue of 92 patients, most of whom had multiple congenital anomalies. Four normal patients were included as controls. In many of the cases, the karotype was already known, and the testing confirmed the success of the CGH technique. In 40 patients, the karotype was unknown but identified by CGH in 90% of the cases. Among these, one additional chromosomal aberration, that of Turner syndrome, was identified.

CGH offered an interpretable result in 93% of the cases tested. The authors concluded that “these techniques are valuable additional tools in the postmortem analysis of fetuses and infants with (multiple) congenital anomalies and can be considered as an expansion of the diagnostic armamentarium of the pathologist.”

For the full text of the article, “The Use of Comparative Genomic Hybridization and Fluorescent In Situ Hybridization in Postmortem Pathology Investigation of Congenital Malformations ,” Pediatric and Developmental Pathology, Volume 13, Issue 2, 2010, visit: http://www2.allenpress.com/pdf/pdpa13.2_85-94.pdf

About Pediatric and Developmental Pathology
Pediatric and Developmental Pathology is the premier journal dealing with the pathology of disease from conception through adolescence. It covers the spectrum of disorders developing in-utero (including embryology, placentology, and teratology), gestational and perinatal diseases, and all diseases of childhood. For more information about the journal or society, please visit: http://www.pedpath.org.

Source:  Allen Press Publishing Services



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  UTSW researchers identify a therapeutic strategy that may treat a childhood neurological disorder
  Siblings of children with autism can show signs at 18 months
  Study finds hazardous flame retardants in preschools
  ADHD drugs not linked to increased stroke risk among children
  Online alcohol marketing easily accessed by kids
  Brain chemical ratios help predict developmental delays in preterm infants
  Common genetic pathway could be conduit to pediatric tumor treatment
  Think twice before buying breast milk online: study
  Child Abuse Ad Shows Hidden Message for Children
  90 percent of pediatric specialists not following clinical guidelines when treating preschoolers with ADHD
  Limited impact on child abuse from visits, intervention: study
  Breathing program may held save newborns’ lives: studies

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site